Clinical trialObsRecruiting
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Biospecimen Resource for Pancreas Disease, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease
- Outcome
- Ongoing
- Phase
- Obs
- Status
- Recruiting
- Study type
- Observational
- Start
- 1 October 2000
- Expected end
- 30 August 2027
- Enrollment
- 20,000 participants
- Sites
- 3
- Primary outcomes
- Collection of clinical data, health and family histories by survey; Collection of blood and/or tissue, fecal and oral specimens; Collection of information regarding food preparation and intake by survey
- Sponsor
- Other
- Results posted
- No
- Last update
- 9 March 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.
Detailed description public domain (ClinicalTrials.gov)
PRIMARY OBJECTIVE: I. To maintain a resource (bank) of biospecimens and data collected from individuals being seen clinically for pancreas conditions to facilitate the discovery and development of (but not limited to) biomarkers of risk (including genomic and proteomic) and early detection as well as novel targeted therapies for pancreatic diseases with a focus on pancreatic cancer. OUTLINE: This is an observational study. Patients undergo blood, saliva, and previously obtained leftover tissue sample collection on study. Patients also complete questionnaires and have their medical records reviewed on study.
Intervention public domain (ClinicalTrials.gov)
Other: medical chart review. baseline, 12 month and 36 months
Intervention public domain (ClinicalTrials.gov)
Other: survey administration. baseline, 6 month, 12 month
Intervention public domain (ClinicalTrials.gov)
Other: biospecimen collection. baseline
Arm public domain (ClinicalTrials.gov)
Observational (): Patients undergo blood, saliva, and previously obtained leftover tissue sample collection on study. Patients also complete questionnaires and have their medical records reviewed on study.
Primary outcome public domain (ClinicalTrials.gov)
Collection of clinical data, health and family histories by survey. Time frame: baseline enrollment, 6 months, 12 months.
Primary outcome public domain (ClinicalTrials.gov)
Collection of blood and/or tissue, fecal and oral specimens. Time frame: baseline.
Primary outcome public domain (ClinicalTrials.gov)
Collection of information regarding food preparation and intake by survey. Time frame: baseline.
Eligibility public domain (ClinicalTrials.gov)
* Known or suspected pancreas disease including: * pancreas adenocarcinoma * islet cell cancer * pancreatic cysts * pancreatitis (hereditary, acute, or chronic) * Next of kin of deceased participant who did not complete participation before passing away Exclusion Criteria: * Under the age of 18 * Unable to provide informed consent * Prison inmates
Enrollment public domain (ClinicalTrials.gov)
Enrollment: 20000 participants (estimated).